Estée Lauder to Release Q3 Fiscal 2026 Results
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 24 2026
0mins
Source: Newsfilter
- Earnings Release Schedule: Estée Lauder Companies Inc. will announce its fiscal 2026 third quarter results on May 1, 2026, at 8:30 a.m. ET, providing a live webcast for the conference call to discuss results, future prospects, and recent corporate developments.
- Executive Leadership: The call will be hosted by President and CEO Stéphane de La Faverie and EVP and CFO Akhil Shrivastava, ensuring investors receive firsthand insights into the company's performance and strategic direction.
- Global Market Presence: Estée Lauder's products are sold in approximately 150 countries and territories, showcasing its strong influence in the luxury market across skincare, makeup, fragrance, and hair care sectors.
- Diverse Brand Portfolio: The company boasts a wide range of renowned brands, including Estée Lauder, Clinique, and M·A·C, further solidifying its leadership position in the beauty industry and attracting a broad consumer base.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy EL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on EL
Wall Street analysts forecast EL stock price to rise
18 Analyst Rating
8 Buy
9 Hold
1 Sell
Moderate Buy
Current: 84.530
Low
70.00
Averages
106.76
High
130.00
Current: 84.530
Low
70.00
Averages
106.76
High
130.00
About EL
The Estee Lauder Companies Inc. is a manufacturer, marketer and seller of skin care, makeup, fragrance and hair care products. Its products are sold in over 150 countries and territories under a number of brand names, including Estee Lauder, Aramis, Clinique, Lab Series, Origins, M.A.C, Bobbi Brown Cosmetics, La Mer, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frederic Malle, GLAMGLOW, Kilian Paris, Too Faced, Dr.Jart+, and the DECIEM family of brands, including The Ordinary and NIOD, and BALMAIN Beauty. It is a license for fragrances, cosmetics and/or related products for AERIN, BALMAIN, and Dr. Andrew Weil. Its skin care products include moisturizers, serums, cleansers, toners, exfoliators, facial masks, body care, sun care products and others. Its makeup products include foundations, powders, concealers and setting sprays, lipsticks, lip liners and lip glosses, and mascaras, eyeshadows and eyeliners.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- New Product Launch: Meta debuted its new line of AI smart glasses priced at $299, aiming to expand market reach by offering a more competitive price point compared to higher-end products from Ray-Ban and Oakley.
- Market Share Control: According to Counterpoint Research, Meta currently holds about 80% of the AI glasses market share, and despite challenges from competitors like Google and Apple, the company is focused on solidifying its market leadership.
- Product Diversification: The new Meta glasses come in three styles, including a collaboration with Kylie Jenner priced at $399, which adds a personalized AI assistant feature to attract a broader consumer base.
- Technological Investment: Meta plans to invest over $145 billion in AI-related hardware by 2026, and while the market remains cautious about its spending, the company is committed to demonstrating the value of its investments through innovation.
See More
- Muted Market Start: The new trading week begins with the S&P 500 indicated flat while the tech-heavy Nasdaq shows slight gains, and WTI crude oil is trading around $76.50 per barrel, reflecting cautious market sentiment regarding economic outlook.
- Abbvie Acquires Apogee: Abbvie is acquiring Apogee Therapeutics for $10.9 billion to strengthen its immunology portfolio, particularly competing with Johnson & Johnson's Tremfya through its top drug Skyrizi, which is expected to enhance Abbvie's competitive edge in the biopharmaceutical market.
- CRH Acquires Arcosa: CRH is acquiring Arcosa for $8.5 billion, stating that the acquisition is highly complementary amid growing demand for energy and utility infrastructure, which is expected to further solidify CRH's position in the construction materials market.
- Estee Lauder Buy Rating Reinstated: Goldman Sachs has reinstated a buy rating for Estee Lauder with a price target of $100, as analysts believe the market is underestimating the company's growth momentum, especially after it walked away from merger talks with Spanish beauty peer Puig.
See More
- Tesla Rating Maintained: Jefferies raised Tesla's price target from $350 to $375, indicating that the stock did not sell off ahead of the SPCX IPO, which suggests a consensus on a potential merger that could turn TSLA into a tracker to minimize shareholder dilution risk.
- Kimco Realty Upgrade: Wolfe upgraded Kimco Realty from Peer Perform to Outperform with a price target of $28, anticipating approximately a 16% total return, reflecting strong fundamentals and signaling a recovery potential in the real estate market.
- Cleveland-Cliffs Downgrade: Morgan Stanley downgraded Cleveland-Cliffs from Overweight to Equal Weight with a new price target of $12.5, indicating a more balanced risk-reward profile in line with peers, reflecting a cautious market sentiment towards the stock.
- Micron Technology Reiteration: Bernstein raised Micron's price target from $510 to $1,300 while maintaining an Outperform rating, driven by optimistic forecasts for conventional memory and high bandwidth memory pricing, highlighting a robust recovery in the semiconductor sector.
See More
- Fragrance Category Growth: In Q1 of fiscal 2026, Ulta Beauty achieved high-teen comp growth in its fragrance category, increasing its revenue share from 11% to 12%, indicating robust performance and sustained growth potential in the fragrance market.
- New Product Sales Boost: The introduction of new products from core luxury brands like YSL, Carolina Herrera, and Valentino, along with NOYZ's innovative milk scent format, significantly enhanced customer interest and drove sales growth, showcasing the company's success in product innovation.
- Marketing Strategy: NOYZ's 360-degree go-to-market activation strategy propelled it into Ulta's top 20 fragrance brands, while the collaboration fragrance “Be Her” with Ella Langley increased brand social engagement, further enhancing consumer awareness and interest.
- Financial Performance Analysis: Despite a 3.8% decline in Ulta's stock price over the past year, its forward P/E ratio of 15.23 is slightly above the industry average of 14.39, reflecting market confidence in its future growth, with earnings expected to rise by 11.8% and 11.3% over the next two fiscal years.
See More
- Industry Growth Drivers: The cosmetics industry benefits from sustained consumer demand for skincare, makeup, and personal care products, prompting companies to invest in innovation and digitalization to enhance customer engagement and expand market reach.
- Innovation and Digitalization: Firms are developing science-backed formulations and clean beauty products to meet consumer demand for differentiated offerings, thereby driving industry growth and enhancing competitive positioning.
- Economic Challenges Response: Despite facing high input and logistics costs, cosmetics companies are navigating economic uncertainties by focusing on omnichannel expansion and operational efficiencies to ensure long-term sustainable growth.
- Optimistic Industry Outlook: The Zacks Cosmetics industry ranks #107, placing it in the top 43% of 247 industries, indicating solid near-term earnings prospects, with consensus estimates for fiscal-year earnings having increased by 17% since April 2026.
See More
- Wealth Growth Fuels Luxury Demand: Analysts highlight that the Kospi Index in South Korea surged 75% in Q2, the S&P 500 rose 15%, and Japan's Nikkei increased by 37%, indicating that significant wealth creation may stimulate demand for luxury brands like LVMH and Moncler.
- SpaceX IPO Boosts Consumer Confidence: Since its IPO, SpaceX's soaring stock price has enhanced the confidence of wealthier consumers, with expectations that luxury spending will rise further by 2026, particularly in the high-end apparel and accessories market.
- Luxury Brands Stand to Benefit: Major luxury brands such as LVMH, Kering, and Hermès are poised to gain from the anticipated consumer spending surge, especially in the Asian and U.S. markets, as their product lines encompass high-end apparel, footwear, and handbags.
- Strong Performance of Luxury ETF: The Amundi Global Luxury UCITS ETF has risen 10% over the past six weeks, reflecting investor optimism about the luxury market and further validating the potential growth trend in luxury demand.
See More











